Shareholders
Institutional and strategic investors back CorTec on its path from first-in-human toward broad clinical use.
Santo Venture Capital GmbH is the venture arm of ATHOS KG, the family office of the Strüngmann families.
The investment companies of the Strüngmann Family Office pursue a long-term investment approach in the biotech and healthcare sectors.
LBBW Venture Capital GmbH is a wholly owned subsidiary of the Landesbank Baden-Württemberg. It offers venture capital financing for companies in the sectors IT, industrial technologies and life science. In addition to this, it administers the “Seedfonds BW” (seed fund Baden-Württemberg) together with the Mittelständische Beteiligungsgesellschaft Baden-Württemberg GmbH (MBG), specifically financing innovative start-up technology companies from Baden-Württemberg in cooperation with High-Tech Gründerfonds.
High-Tech Gründerfonds invests in young, high potential high-tech start-ups. The seed financing provided is designed to enable start-ups to take an idea through prototyping and to market launch. Typically, High-Tech Gründerfonds invests initially 1 million EUR in the seed stage, with the potential for up to a total of EUR 3 million per portfolio company in follow-on financing. High-Tech Gründerfonds has a total fund volume of around EUR 895.5 million.
Mangold Invest bundles the industrial investments of the Mangold family (Stuttgart) under the management of Prof. Dr. Klaus Mangold and Dr. Christoph Mangold. Mangold Invest follows a long-term investment approach in the areas of private equity, real estate as well as agriculture and forestry. All investments are led personally and the management is either directly supported or guided over an active advisory board.
The company is a subsidiary of Mangold Consulting GmbH which was founded in 2003 by Prof. Dr. Klaus Mangold, a former member of the board of Daimler and chairman of the German Committee on Eastern European Economic Relations (Ostausschuss der deutschen Wirtschaft). Since then, the company advises successfully projects of well-known companies in Europe, Russia and Central Asia and has a distinctive network in German industry as well as in the mentioned regions.
The KfW Banking Group is Germany’s leading financier of SMEs. It provides companies with long-term investment loans as well as with working capital financing loans.
In addition to this, KfW supports innovative companies with special equity capital programs. With the ERP-Start Fund, it acquires a particular interest in young, innovative, and technology-oriented companies with high growth prospects – always together with private venture capital investors and under the same conditions. Both research and product development and the launch of new products, technologies or services are being financed.
M-Invest is a private investment company founded by Bernhard and Tobias Meder. Bernhard Meder also founded MEDER electronic, a company for switching technology operating wordwide which merged with Standex Electronics in 2012.
M-Invest does not consider itself a mere financial investor. The company also supports young enterprises with an innovative business idea in their marketing, business development, establishment of sales as well as other entrepreneurial know-how.
The K & S W Invest GmbH mainly works as a seed investor for internationally oriented German companies in the field of medical engineering. Klaus Würtenberger, who was already responsible for shaping the development of Berlin Heart GmbH as chairman and partner from 2001 to 2007, is the CEO of K & S W Invest. Klaus Würtenberger is also an accredited coach for High-Tech Gründerfonds, Bonn, and BWcon, Stuttgart.
The European Innovation Council (EIC) is the European Union's flagship programme for supporting breakthrough innovation. Through the EIC Fund, it makes direct equity investments in high-potential deep-tech companies developing technologies with strong societal impact, helping them scale from early development toward market and clinical adoption. The EIC combines this investment with grant funding and non-financial support, backing companies that advance strategically important technologies in Europe.
Why CorTec
Read the full why CorTec page, or contact our team to request the current investor materials.
This page is for information only and does not constitute an offer of securities or investment advice.
